BlueWind Medical today announced two-year results from a study of its Revi implantable tibial neuromodulation (iTNM) system.

Neuronetics (Nasdaq:STIM) announced today that it priced an underwritten public offering of common stock at approximately $18 ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

The FDA labeled a recall of integrated arterial catheters made by Medline Class I, the most serious kind of recall.